p-Aminosalicylsaeure en es it fr

p-Aminosalicylsaeure Brand names, p-Aminosalicylsaeure Analogs

p-Aminosalicylsaeure Brand Names Mixture

  • No information avaliable

p-Aminosalicylsaeure Chemical_Formula

C6H11NO3

p-Aminosalicylsaeure RX_link

No information avaliable

p-Aminosalicylsaeure fda sheet

p-Aminosalicylsaeure FDA

p-Aminosalicylsaeure msds (material safety sheet)

p-Aminosalicylsaeure Synthesis Reference

No information avaliable

p-Aminosalicylsaeure Molecular Weight

145.156 g/mol

p-Aminosalicylsaeure Melting Point

No information avaliable

p-Aminosalicylsaeure H2O Solubility

Freely soluble

p-Aminosalicylsaeure State

Solid

p-Aminosalicylsaeure LogP

-1.026

p-Aminosalicylsaeure Dosage Forms

Cream for topical administration (160 mg/g of methyl aminolevulinate equivalent to 16.0% of methyl aminolevulinate)

p-Aminosalicylsaeure Indication

For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).

p-Aminosalicylsaeure Pharmacology

After topical application of methyl aminolevulinate, porphyrins will accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PpIX) are photoactive, fluorescing compounds and, upon light activation in the presence of oxygen, singlet oxygen is formed which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells.

p-Aminosalicylsaeure Absorption

In vitro, after 24 hours the mean cumulative absorption through human skin was 0.26% of the administered dose.

p-Aminosalicylsaeure side effects and Toxicity

The severity of local phototoxic reactions such as erythema, pain and burning sensation may increase in case of prolonged application time or very high light intensity.

p-Aminosalicylsaeure Patient Information

p-Aminosalicylsaeure Organisms Affected

Humans and other mammals